Soo Young Jeong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Soo Young Jeong has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Sung Taek Park
Institute of New Frontier Research Team, Hallym University, Chuncheon 24252, Republic of Korea
3 shared publications - Byoung-Gie Kim
Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
2 shared publications - Ji-Hee Sung
Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
2 shared publications - Anna DeFazio
The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia
1 shared publication Australian Ovarian Cancer Study Group
Peter MacCallum Cancer Centre, Melbourne, Victoria
1 shared publication- Byung Kwan Park
Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by XMLink in Yonsei Medical Journal
- Vol. 67 (6) , 502-507
The Role of YouTube as an Information Platform for Ovarian Cancer: the Educational Quality and Reliability
Jeong SY, et al. Yonsei Med J. 2026 Jun;67(6):502-507. https://doi.org/10.3349/ymj.2025.0374
- 1 January 2026
- Published by XMLink in Yonsei Medical Journal
- Vol. 67 (6) , 502-507
Open AccessThe Role of YouTube as an Information Platform for Ovarian Cancer: the Educational Quality and Reliability
Jeong SY, et al. Yonsei Med J. 2026 Jun;67(6):502-507. https://doi.org/10.3349/ymj.2025.0374
- Open Access
- 1 January 2023
- Published by XMLink in Perinatology
- Vol. 34 (4) , 190-195
Spontaneous Uterine Rupture at 22 Weeks’ Gestation in a Woman Who Underwent Abdominal Adenomyomectomy: A Case Report
Uterine rupture during pregnancy, while quite rare, can have devastating consequences for both mother and fetus if it does occur. Uterine surgery is recognized risk factor for uterine rupture during pregnancy. Presently, adenomyomectomy is performed not infrequently as a treatment for infertility. However, the potential adverse outcomes associated with this procedure have not been extensively investigated. We report a case of spontaneous uterine rupture at 22 weeks of gestation following adenomyomectomy, leading to a stillbirth and maternal hypovolemic shock due to severe hemorrhage. If a pregnant woman with a history of uterine surgery presents with sudden abdominal pain, uterine rupture must be considered as a differential diagnosis. Given that spontaneous uterine rupture after adenomyomectomy can occur in the second trimester of pregnancy, it is crucial for patients with adenomyosis desiring to conceive to carefully consider the implications and risk of undergoing adenomyomectomy.
- 1 January 2023
- Published by XMLink in Perinatology
- Vol. 34 (4) , 190-195
Open AccessSpontaneous Uterine Rupture at 22 Weeks’ Gestation in a Woman Who Underwent Abdominal Adenomyomectomy: A Case Report
Uterine rupture during pregnancy, while quite rare, can have devastating consequences for both mother and fetus if it does occur. Uterine surgery is recognized risk factor for uterine rupture during pregnancy. Presently, adenomyomectomy is performed not infrequently as a treatment for infertility. However, the potential adverse outcomes associated with this procedure have not been extensively investigated. We report a case of spontaneous uterine rupture at 22 weeks of gestation following adenomyomectomy, leading to a stillbirth and maternal hypovolemic shock due to severe hemorrhage. If a pregnant woman with a history of uterine surgery presents with sudden abdominal pain, uterine rupture must be considered as a differential diagnosis. Given that spontaneous uterine rupture after adenomyomectomy can occur in the second trimester of pregnancy, it is crucial for patients with adenomyosis desiring to conceive to carefully consider the implications and risk of undergoing adenomyomectomy.
- Open Access
- 14 February 2022
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 27 (2) , 60-060
Prognostic value of protein tyrosine kinase 6 overexpression in cancers: a meta-analysis
Background: Protein tyrosine kinase 6 (PTK6) plays an important role in cell proliferation and differentiation. However, the functions of PTK6 appear highly context-dependent and differ depending on the cell type, as well as its intracellular localization. High PTK6 expression in tumor has been associated with poor pathological features and prognosis in some studies, but other studies have reported opposite results. Therefore, we performed this meta-analysis to derive more precise estimations of the association of PTK6 expression with prognosis and clinicopathological features in cancer patients. Methods: We conducted a literature search in PubMed, Ovid MEDLINE, and MEDLINE databases to cover all articles published until June 2021. All 1475 patients from the eight studies were included in the meta-analysis. Because of heterogeneity in PTK6 expression in non-tumor tissues, the included studies were divided into two subgroups according to PTK expression in non-tumor tissues: the low expression subgroup (LESG) or high expression subgroup (HESG). Results: Patients with high PTK expression showed significantly worse overall survival (OS) in LESG (Hazard Ratio (HR) = 2.53 [95% Confidence Interval (CI), 1.68–3.83], p < 0.0001), but significantly better OS in HESG (HR = 0.56 [95% CI, 0.40–0.78], p = 0.0006). PTK6 expression also showed different associations with clinicopathological features, such as advanced T classification, stage, and differentiation according to PTK6 expression in non-tumor tissues. Conclusions: PTK6 expression in tumor was a prognostic factor in patients with various cancers, but the direction of prognosis differs, depending on the degree of PTK6 expression in non-tumor tissues.
- 14 February 2022
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 27 (2) , 60-060
Open AccessPrognostic value of protein tyrosine kinase 6 overexpression in cancers: a meta-analysis
Background: Protein tyrosine kinase 6 (PTK6) plays an important role in cell proliferation and differentiation. However, the functions of PTK6 appear highly context-dependent and differ depending on the cell type, as well as its intracellular localization. High PTK6 expression in tumor has been associated with poor pathological features and prognosis in some studies, but other studies have reported opposite results. Therefore, we performed this meta-analysis to derive more precise estimations of the association of PTK6 expression with prognosis and clinicopathological features in cancer patients. Methods: We conducted a literature search in PubMed, Ovid MEDLINE, and MEDLINE databases to cover all articles published until June 2021. All 1475 patients from the eight studies were included in the meta-analysis. Because of heterogeneity in PTK6 expression in non-tumor tissues, the included studies were divided into two subgroups according to PTK expression in non-tumor tissues: the low expression subgroup (LESG) or high expression subgroup (HESG). Results: Patients with high PTK expression showed significantly worse overall survival (OS) in LESG (Hazard Ratio (HR) = 2.53 [95% Confidence Interval (CI), 1.68–3.83], p < 0.0001), but significantly better OS in HESG (HR = 0.56 [95% CI, 0.40–0.78], p = 0.0006). PTK6 expression also showed different associations with clinicopathological features, such as advanced T classification, stage, and differentiation according to PTK6 expression in non-tumor tissues. Conclusions: PTK6 expression in tumor was a prognostic factor in patients with various cancers, but the direction of prognosis differs, depending on the degree of PTK6 expression in non-tumor tissues.
- Open Access
- 11 January 2022
- Published by IMR Press in Clinical and Experimental Obstetrics & Gynecology
- Vol. 49 (1)
A retrospective comparative analysis of systemic inflammatory response after laparoscopic, vaginal, and abdominal hysterectomy
Background: Lymphocyte to neutrophil ratio (NLR) is a rapid and simple marker for systemic inflammation and stress after major surgery. In this study, we aimed to compare NLR changes according to surgical methods of hysterectomy. Methods: A retrospective chart review for all patients who underwent hysterectomy for benign uterine disease from 2016 to 2020 was performed. A total of 1549 women were assigned to total laparoscopic hysterectomy (TLH) (n = 419), vaginal hysterectomy (VH) (n = 608), and total abdominal hysterectomy (TAH) (n = 522) groups. Patient characteristics, surgical outcomes, and NLR changes were compared among women who underwent TLH, VH, and TAH. Results: Preoperative mean NLR was similar among three groups (p = 0.056). However, mean NLR on postoperative day 1 (p< 0.0001) and day 3 (p = 0.011) was significantly lower in TLH group than others. Also, mean NLR change on postoperative day 1 was significantly lesser in TLH group than others (1.9 in TLH vs. 5.4 in VH vs. 4.7 in TAH; p < 0.0001). Mean NLR change on postoperative day 3 was greater in TAH group than others, although there were no statistically significant differences (0.2 in TLH vs. 0.3 in VH vs. 0.7 in TAH; p = 0.354). Multivariate analysis revealed that massive NLR change (>5.0) on postoperative day 1 was significantly associated with types of hysterectomy (p < 0.0001). Conclusion: Our data showed that acute NLR change was lesser in TLH group comparing to VH and TAH group, which suggests that TLH might be associated with less systemic inflammation and tissue trauma after surgery.
- 11 January 2022
- Published by IMR Press in Clinical and Experimental Obstetrics & Gynecology
- Vol. 49 (1)
Open AccessA retrospective comparative analysis of systemic inflammatory response after laparoscopic, vaginal, and abdominal hysterectomy
Background: Lymphocyte to neutrophil ratio (NLR) is a rapid and simple marker for systemic inflammation and stress after major surgery. In this study, we aimed to compare NLR changes according to surgical methods of hysterectomy. Methods: A retrospective chart review for all patients who underwent hysterectomy for benign uterine disease from 2016 to 2020 was performed. A total of 1549 women were assigned to total laparoscopic hysterectomy (TLH) (n = 419), vaginal hysterectomy (VH) (n = 608), and total abdominal hysterectomy (TAH) (n = 522) groups. Patient characteristics, surgical outcomes, and NLR changes were compared among women who underwent TLH, VH, and TAH. Results: Preoperative mean NLR was similar among three groups (p = 0.056). However, mean NLR on postoperative day 1 (p< 0.0001) and day 3 (p = 0.011) was significantly lower in TLH group than others. Also, mean NLR change on postoperative day 1 was significantly lesser in TLH group than others (1.9 in TLH vs. 5.4 in VH vs. 4.7 in TAH; p < 0.0001). Mean NLR change on postoperative day 3 was greater in TAH group than others, although there were no statistically significant differences (0.2 in TLH vs. 0.3 in VH vs. 0.7 in TAH; p = 0.354). Multivariate analysis revealed that massive NLR change (>5.0) on postoperative day 1 was significantly associated with types of hysterectomy (p < 0.0001). Conclusion: Our data showed that acute NLR change was lesser in TLH group comparing to VH and TAH group, which suggests that TLH might be associated with less systemic inflammation and tissue trauma after surgery.
- Open Access
- 1 January 2022
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 34 (1)
Contrasting clinical characteristics and treatment patterns in women with newly diagnosed advanced-stage epithelial ovarian cancer in Australia, South Korea and Taiwan
Chou HH, et al. J Gynecol Oncol. 2022 Oct;34:e3. https://doi.org/10.3802/jgo.2023.34.e3
- 1 January 2022
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 34 (1)
Open AccessContrasting clinical characteristics and treatment patterns in women with newly diagnosed advanced-stage epithelial ovarian cancer in Australia, South Korea and Taiwan
Chou HH, et al. J Gynecol Oncol. 2022 Oct;34:e3. https://doi.org/10.3802/jgo.2023.34.e3
- Open Access
- 1 February 2020
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 27 (2) , 473-481
In Vivo Comparison of MONOFIX, A Novel Barbed Suture with a Triangular Stopper, with Pre-existing Products in a Porcine Model
- 1 February 2020
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 27 (2) , 473-481
Open AccessIn Vivo Comparison of MONOFIX, A Novel Barbed Suture with a Triangular Stopper, with Pre-existing Products in a Porcine Model
- Open Access
- 1 January 2020
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 31 (4)
Epithelial ovarian cancer: a review of preoperative imaging features indicating suboptimal surgery
Jeong SY, et al. J Gynecol Oncol. 2019 Jun;31:e57. https://doi.org/10.3802/jgo.2020.31.e57
- 1 January 2020
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 31 (4)
Open AccessEpithelial ovarian cancer: a review of preoperative imaging features indicating suboptimal surgery
Jeong SY, et al. J Gynecol Oncol. 2019 Jun;31:e57. https://doi.org/10.3802/jgo.2020.31.e57
- Open Access
- 1 January 2017
- Published by XMLink in Journal of Korean Medical Science
- Vol. 32 (10) , 1717-1720
MERS-CoV Infection in a Pregnant Woman in Korea
Jeong SY, et al. J Korean Med Sci. 2017 Oct;32(10):1717-1720. https://doi.org/10.3346/jkms.2017.32.10.1717
- 1 January 2017
- Published by XMLink in Journal of Korean Medical Science
- Vol. 32 (10) , 1717-1720
Open AccessMERS-CoV Infection in a Pregnant Woman in Korea
Jeong SY, et al. J Korean Med Sci. 2017 Oct;32(10):1717-1720. https://doi.org/10.3346/jkms.2017.32.10.1717